217 related articles for article (PubMed ID: 27882937)
1. EZH2 mediates lidamycin-induced cellular senescence through regulating p21 expression in human colon cancer cells.
Sha MQ; Zhao XL; Li L; Li LH; Li Y; Dong TG; Niu WX; Jia LJ; Shao RG; Zhen YS; Wang Z
Cell Death Dis; 2016 Nov; 7(11):e2486. PubMed ID: 27882937
[TBL] [Abstract][Full Text] [Related]
2. PTTG1 attenuates drug-induced cellular senescence.
Tong Y; Zhao W; Zhou C; Wawrowsky K; Melmed S
PLoS One; 2011; 6(8):e23754. PubMed ID: 21858218
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells.
Li Y; Li D; Zhao M; Huang S; Zhang Q; Lin H; Wang W; Li K; Li Z; Huang W; Che Y; Huang C
Life Sci; 2018 Sep; 208():295-304. PubMed ID: 30031062
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
5. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
[TBL] [Abstract][Full Text] [Related]
6. Difference of cell cycle arrests induced by lidamycin in human breast cancer cells.
Liu X; He H; Feng Y; Zhang M; Ren K; Shao R
Anticancer Drugs; 2006 Feb; 17(2):173-9. PubMed ID: 16428935
[TBL] [Abstract][Full Text] [Related]
7. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.
Chen Y; Pan K; Wang P; Cao Z; Wang W; Wang S; Hu N; Xue J; Li H; Jiang W; Li G; Zhang X
J Biol Chem; 2016 Jun; 291(24):12688-12705. PubMed ID: 27129219
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis.
Pan Y; Ren KH; He HW; Shao RG
Cancer Biol Ther; 2009 Aug; 8(16):1559-66. PubMed ID: 19502782
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target.
Cao J; Pontes KC; Heijkants RC; Brouwer NJ; Groenewoud A; Jordanova ES; Marinkovic M; van Duinen S; Teunisse AF; Verdijk RM; Snaar-Jagalska E; Jochemsen AG; Jager MJ
J Pathol; 2018 Aug; 245(4):433-444. PubMed ID: 29732557
[TBL] [Abstract][Full Text] [Related]
10. [Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
Shang BY; Shang Y; Zhen YS; Chen SZ
Yao Xue Xue Bao; 2011 Nov; 46(11):1321-5. PubMed ID: 22260022
[TBL] [Abstract][Full Text] [Related]
11. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.
Fan T; Jiang S; Chung N; Alikhan A; Ni C; Lee CC; Hornyak TJ
Mol Cancer Res; 2011 Apr; 9(4):418-29. PubMed ID: 21383005
[TBL] [Abstract][Full Text] [Related]
12. MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21.
Liu L; Xu F; Chang CK; He Q; Wu LY; Zhang Z; Li X
Cell Death Dis; 2017 Oct; 8(10):e3126. PubMed ID: 29022893
[TBL] [Abstract][Full Text] [Related]
13. Hsp90 inhibitor geldanamycin enhances the antitumor efficacy of enediyne lidamycin in association with reduced DNA damage repair.
Han FF; Li L; Shang BY; Shao RG; Zhen YS
Asian Pac J Cancer Prev; 2014; 15(17):7043-8. PubMed ID: 25227788
[TBL] [Abstract][Full Text] [Related]
14. Lidamycin induces marked G2 cell cycle arrest in human colon carcinoma HT-29 cells through activation of p38 MAPK pathway.
Liu X; Bian C; Ren K; Jin H; Li B; Shao RG
Oncol Rep; 2007 Mar; 17(3):597-603. PubMed ID: 17273739
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting enhancer of zeste homolog 2 promotes cellular senescence in gastric cancer cells SGC-7901 by activation of p21 and p16.
Bai J; Chen J; Ma M; Cai M; Xu F; Wang G; Tao K; Shuai X
DNA Cell Biol; 2014 Jun; 33(6):337-44. PubMed ID: 24588771
[TBL] [Abstract][Full Text] [Related]
16. P53 dependent and independent apoptosis induced by lidamycin in human colorectal cancer cells.
Chen L; Jiang J; Cheng C; Yang A; He Q; Li D; Wang Z
Cancer Biol Ther; 2007 Jun; 6(6):965-73. PubMed ID: 17534142
[TBL] [Abstract][Full Text] [Related]
17. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer.
Liu JQ; Feng YH; Zeng S; Zhong MZ
Life Sci; 2020 Jan; 241():117134. PubMed ID: 31811854
[TBL] [Abstract][Full Text] [Related]
18. Effect of lidamycin on telomerase activity in human hepatoma BEL-7402 cells.
Gao RJ; Liang YX; Li DD; Zhang HY; Zhen YS
Biomed Environ Sci; 2007 Jun; 20(3):189-97. PubMed ID: 17672208
[TBL] [Abstract][Full Text] [Related]
19. Lnc-IL7R alleviates PM
Lee KY; Ho SC; Sun WL; Feng PH; Lin CW; Chen KY; Chuang HC; Tseng CH; Chen TT; Wu SM
Cell Biol Toxicol; 2022 Dec; 38(6):1097-1120. PubMed ID: 35303175
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.
Yu Y; Qi J; Xiong J; Jiang L; Cui D; He J; Chen P; Li L; Wu C; Ma T; Shao S; Wang J; Yu D; Zhou B; Huang D; Schmitt CA; Tao R
Theranostics; 2019; 9(3):761-777. PubMed ID: 30809307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
